Thomas A Mccourt is Chief Executive Officer of IRONWOOD PHARMACEUTICALS INC. Currently has a direct ownership of 1.15 Million shares of IRWD, which is worth approximately $4.87 Million. The most recent transaction as insider was on May 20, 2024, when has been sold 67,618 shares (Class A Common Stock) at a price of $6.45 per share, resulting in proceeds of $436,136. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.15M
0% 3M change
51.7% 12M change
Total Value Held $4.87 Million

Thomas A MCCOURT Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 20 2024
SELL
Open market or private sale
$436,136 $6.45 p/Share
67,618 Reduced 5.55%
1,150,330 Class A Common Stock
Mar 08 2024
BUY
Exercise of conversion of derivative security
-
120,298 Added 8.99%
1,217,948 Class A Common Stock
Mar 05 2024
BUY
Grant, award, or other acquisition
-
264,876 Added 19.44%
1,097,650 Class A Common Stock
Feb 12 2024
SELL
Open market or private sale
$2,699,979 $15.24 p/Share
177,164 Reduced 17.54%
832,774 Class A Common Stock
Jan 17 2024
BUY
Grant, award, or other acquisition
-
249,617 Added 19.82%
1,009,938 Class A Common Stock
May 30 2023
SELL
Open market or private sale
$284,962 $10.7 p/Share
26,632 Reduced 3.39%
758,284 Class A Common Stock
May 22 2023
SELL
Open market or private sale
$364,320 $10.12 p/Share
36,000 Reduced 4.39%
784,916 Class A Common Stock
May 08 2023
SELL
Open market or private sale
$224,591 $10.62 p/Share
21,148 Reduced 2.51%
820,916 Class A Common Stock
Mar 27 2023
SELL
Open market or private sale
$492,196 $10.67 p/Share
46,129 Reduced 5.19%
842,064 Class A Common Stock
Mar 08 2023
BUY
Grant, award, or other acquisition
-
240,595 Added 21.31%
888,193 Class A Common Stock
Mar 03 2023
SELL
Open market or private sale
$378,742 $11.22 p/Share
33,756 Reduced 4.95%
647,598 Class A Common Stock
Feb 28 2023
SELL
Open market or private sale
$353,177 $11.31 p/Share
31,227 Reduced 4.38%
681,354 Class A Common Stock
Feb 27 2023
SELL
Open market or private sale
$342,345 $11.41 p/Share
30,004 Reduced 4.04%
712,581 Class A Common Stock
Jan 17 2023
BUY
Grant, award, or other acquisition
-
30,145 Added 3.9%
742,585 Class A Common Stock
Jan 05 2023
SELL
Open market or private sale
$1,339,311 $12.07 p/Share
110,962 Reduced 13.48%
712,440 Class A Common Stock
Jan 05 2023
BUY
Exercise of conversion of derivative security
$1,292,707 $11.65 p/Share
110,962 Added 11.88%
823,402 Class A Common Stock
Oct 03 2022
SELL
Open market or private sale
$196,739 $10.41 p/Share
18,899 Reduced 2.58%
712,440 Class A Common Stock
Sep 01 2022
SELL
Open market or private sale
$281,650 $10.65 p/Share
26,446 Reduced 3.49%
731,339 Class A Common Stock
Aug 01 2022
SELL
Open market or private sale
$263,649 $11.35 p/Share
23,229 Reduced 2.97%
757,785 Class A Common Stock
Jun 30 2022
SELL
Open market or private sale
$231,125 $11.58 p/Share
19,959 Reduced 2.5%
778,922 Class A Common Stock
May 23 2022
SELL
Open market or private sale
$417,542 $11.5 p/Share
36,308 Reduced 4.35%
798,881 Class A Common Stock
Mar 08 2022
BUY
Grant, award, or other acquisition
-
248,869 Added 22.96%
835,189 Class A Common Stock
Feb 28 2022
SELL
Open market or private sale
$521,527 $10.77 p/Share
48,424 Reduced 7.63%
586,320 Class A Common Stock
Jan 19 2022
BUY
Grant, award, or other acquisition
-
60,290 Added 8.67%
634,744 Class A Common Stock
Dec 22 2021
SELL
Open market or private sale
$528,591 $11.41 p/Share
46,327 Reduced 7.46%
574,454 Class A Common Stock

Also insider at

XLRN
ACCELERON PHARMA INC Healthcare
PLRX
PLIANT THERAPEUTICS, INC. Healthcare
TAM

Thomas A Mccourt

Chief Executive Officer
Boston, MA

Track Institutional and Insider Activities on IRWD

Follow IRONWOOD PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IRWD shares.

Notify only if

Insider Trading

Get notified when an Ironwood Pharmaceuticals Inc insider buys or sells IRWD shares.

Notify only if

News

Receive news related to IRONWOOD PHARMACEUTICALS INC

Track Activities on IRWD